TLR7 and systemic lupus erythematosus: Consistent with these findings, the present study showed that lupus MDSCs significantly worsened the disease in a lupus mouse model induced by the TLR7 agonist IMQ, further confirming that MDSCs play a critical pathogenic role in lupus pathogenesis and suggesting that targeting MDSCs may be an effective strategy for lupus treatment.